mesenchymal cells

Hoping for approval, Mesoblast says FDA wants new remestemcel-L trial

mesoblast ceo dr silvio itescu

Australian biotech Mesoblast has had a rollercoaster ride working toward FDA approval of its mesenchymal cell therapy product remestemcel-L. They are seeking approval for use in patients with graft-versus-host disease (GvHD). More specifically, it is intended for pediatric patients with steroid-refractory acute graft versus host disease, or SR-aGVHD. This is a serious condition and new treatment …

Hoping for approval, Mesoblast says FDA wants new remestemcel-L trial Read More »

Boning up on stem cells for osteoporosis: good idea, little data so far

osteoporosis, stem cells for osteoporosis

It’s great when an idea like stem cells for osteoporosis just makes so much common sense, but it still requires data. A logical hypothesis is not enough. The point of today’s post is to fact-check the idea of using stem cells for such bone loss. A femur to stand on? Unfortunately, the take-home message is …

Boning up on stem cells for osteoporosis: good idea, little data so far Read More »